KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Income towards Parent Company (2016 - 2025)

Astrana Health's Income towards Parent Company history spans 16 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Income towards Parent Company fell 94.32% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $9.7 million, down 83.1%, while the annual FY2024 figure was $49.9 million, 13.69% down from the prior year.
  • Income towards Parent Company for Q3 2025 was $1.1 million at Astrana Health, down from $10.2 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $57.6 million in Q2 2021 and bottomed at -$18.2 million in Q4 2021.
  • The 5-year median for Income towards Parent Company is $11.4 million (2022), against an average of $11.5 million.
  • The largest annual shift saw Income towards Parent Company skyrocketed 543.85% in 2022 before it crashed 8262.37% in 2024.
  • A 5-year view of Income towards Parent Company shows it stood at -$18.2 million in 2021, then soared by 95.14% to -$883000.0 in 2022, then surged by 89.47% to -$93000.0 in 2023, then plummeted by 8262.37% to -$7.8 million in 2024, then surged by 113.86% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Income towards Parent Company are $1.1 million (Q3 2025), $10.2 million (Q2 2025), and $6.2 million (Q1 2025).